Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation

Abstract Background Low- and middle-income countries (LMICs) account for nearly 85% of the global cervical cancer burden, yet have the least access to high-performance screening. International guidelines recommend human papillomavirus testing (HPV) as primary screening, yet implementation is inhibit...

Full description

Bibliographic Details

Main Authors:	Sikhulile Moyo, Doreen Ramogola-Masire, Natasha O. Moraka, Leabaneng Tawe, Farzad Noubary, Kesego Motsumi, Godiraone Manowe, Boitumelo Zuze, Botshelo Radibe, Faith T. T. Hungwe, Terence Mohammed, Comfort Maphorisa, Roger Shapiro, Simani Gaseitsiwe, Rebecca Luckett
Format:	Artigo
Language:	Inglês
Published:	BMC 2023-05-01
Series:	Infectious Agents and Cancer
Subjects:	Human papillomavirus (HPV) Cervical screening AmpFire Xpert Human immunodeficiency virus (HIV) Cervical precancer
Online Access:	https://doi.org/10.1186/s13027-023-00504-z
Tags:	Add Tag No Tags, Be the first to tag this record!